PD-L1在溃疡性结肠炎患者及小鼠结肠炎模型结肠黏膜的表达及其作用初探

宋娅岚; 吴天宇; 陈聪; 武振宇; 汤旭东; 陈磊

doi:10.16016/j.2097-0927.202210100

您当前的位置：

首页 >

文章列表页 >

PD-L1在溃疡性结肠炎患者及小鼠结肠炎模型结肠黏膜的表达及其作用初探

基础医学 | 更新时间：2026-01-09

- PD-L1在溃疡性结肠炎患者及小鼠结肠炎模型结肠黏膜的表达及其作用初探
- Expression and role of PD-L1 in colonic mucosa of ulcerative colitis patients and DSS-induced colitis mouse model
- 陆军军医大学学报 2023年45卷第2期页码：155-164
- 作者机构：
  
  400038 重庆，陆军军医大学(第三军医大学)第一附属医院消化内科
- 作者简介：
  
  [陈磊, E-mail：chenlei1977603@126.com CHEN Lei, E-mail: chenlei1977603@126.com
- 基金信息：
  
  国家自然科学基金面上项目(81470850)
- DOI：10.16016/j.2097-0927.202210100
  中图分类号： R361.2;R392.32;R574.62
- 收稿：2022-10-13，
  
  修回：2022-12-06，
  
  纸质出版：2023-01-30
- 稿件说明：
移动端阅览
宋娅岚, 吴天宇, 陈聪, 等. PD-L1在溃疡性结肠炎患者及小鼠结肠炎模型结肠黏膜的表达及其作用初探[J]. 陆军军医大学学报, 2023,45(2):155-164.

Yalan SONG, Tianyu WU, Cong CHEN, et al. Expression and role of PD-L1 in colonic mucosa of ulcerative colitis patients and DSS-induced colitis mouse model[J]. Journal of Army Medical University, 2023, 45(2): 155-164.
宋娅岚, 吴天宇, 陈聪, 等. PD-L1在溃疡性结肠炎患者及小鼠结肠炎模型结肠黏膜的表达及其作用初探[J]. 陆军军医大学学报, 2023,45(2):155-164. DOI： 10.16016/j.2097-0927.202210100.

Yalan SONG, Tianyu WU, Cong CHEN, et al. Expression and role of PD-L1 in colonic mucosa of ulcerative colitis patients and DSS-induced colitis mouse model[J]. Journal of Army Medical University, 2023, 45(2): 155-164. DOI： 10.16016/j.2097-0927.202210100.

摘要

探讨细胞程序性死亡配体-1(programmed cell death-ligand 1

PD-L1)在溃疡性结肠炎(ulcerative colitis

UC)发病机制中的作用。

方法

收集2022年1-9月于陆军军医大学第一附属医院消化内科肠镜室就诊的18~64岁的UC患者结肠组织标本29例

同期收集非UC患者结肠组织标本22例

采用免疫组化和RT-qPCR检测

1和炎症因子

-1

、

-6、

-17

、

-22、

TGF

1的表达。选取8~10周龄C57BL/6雄性小鼠24只(23~26 g)

分为空白对照组(

=4)、PD-L1-Fc组(

=4)、葡聚糖硫酸钠(dextran sulfate sodium salt

DSS)组(

=8)、DSS+PD-L1-Fc组(

=8)

DSS组及DSS+PD-L1-Fc组连续7天予以2.5% DSS溶液自由饮水

第8天更换为正常饮水

其余组

正常饮水

第3天予以PD-L1-Fc组及DSS+PD-L1-Fc组小鼠腹腔注射PD-L1-Fc蛋白(1 mg/mL)40μg/只

造模后8~10天检测各组小鼠结肠黏膜中PD-L1的表达情况

并观察各组小鼠的体质量、粪便性状、活体结肠黏膜形态变化、组织病理学改变及炎症因子改变情况。

结果

与对照组相比

UC患者结肠黏膜中PD-L1表达显著升高(43.03±4.044

0.001)

促炎因子

-1

、

-6及抗炎因子

-22、

TGF

1的表达均升高(

0.05);在DSS小鼠模型中同样存在这一现象。腹腔注射PD-L1-Fc蛋白后

DSS小鼠的体质量、粪便评分、结肠黏膜大体形态及显微镜下炎症程度明显改善(

0.05)

-6、

-17

下调(

0.05)

-22、

Foxp

3上调(

0.05)。

结论

1在UC患者及小鼠DSS结肠炎模型中升高

可能是机体的一种适应性保护作用。

Abstract

Objective

To explore the role of programmed cell death-ligand 1(PD-L1) in pathogenesis of ulcerative colitis (UC).

Methods

A total of 29 colon tissue samples from UC patients aged 18~64 years who underwent the colonoscopy in our department from January 2022 to September 2022 were collected

and another 22 colon tissue samples from non-UC patients were also collected during the same period.The expression of

1 and inflammatory factors

-1

-6

-17

-22 and

TGF

1 were detected by immunohistochemistry and RT-qPCR.Twenty-four male C57BL/6 mice (8~10 weeks old

23~26 g) were randomly divided into blank control group (

=4)

PD-L1-Fc group (

=4)

dextran sulfate sodium salt (DSS) group (

=8)

and DSS+PD-L1-Fc group (

=8).The mice from the DSS group and DSS+PD-L1-Fc group were given 2.5% DSS solution for 7 consecutive days

and were chang

ed to normal drinking water on the 8th day.The animals of the other groups were given normal drinking water.On the 3rd day

the mice in the PD-L1-Fc group and DSS+PD-L1-Fc group were injected intraperitoneally with PD-L1-Fc protein (1 mg/mL

40 μg/animal).In 8~10 d after modeling

the expression of

1 in colonic mucosa was detected

and the body weight

fecal traits

morphological changes

histopathological changes and inflammatory factors were observed in different groups.

Results

The expression of

1 was significantly increased in the colonic mucosa of UC patients (43.03±4.044

0.001) than of normal colon tissue samples

and the expression of pro-inflammatory factors

-1

and

-6 and anti-inflammatory factors

-22 and

TGF

1 were increased (

0.05)

which also existed in DSS mouse models.Intraperitoneal injection of PD-L1-Fc protein improved body weight

fecal score

gross morphology of colonic mucosa and microscopic inflammation (

0.05)

down-regulated

-6 and

-17

(

0.05) and up-regulated

-22 and

Foxp

0.05) in the DSS+PD-L1-Fc mice when compared with the DSS group.

Conclusion

The upregulation of

1 in UC patients and DSS-induced colitis mouse models may play an adaptive protective role.

关键词

Keywords

references

NG S C, SHI H Y, HAMIDI N, et al . Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies[J ] . Lancet, 2017, 390(10114): 2769-2778. DOI: 10.1016/S0140-6736(17)32448-0.

SUN M, HE C, CONG Y, et al . Regulatory immune cells in regulation of intestinal inflammatory response to microbiota[J ] . Mucosal Immunol, 2015, 8(5): 969-978. DOI: 10.1038/mi.2015.49.

SIAKAVELLAS S I, BAMIAS G. Checkpoint inhibitor colitis: a new model of inflammatory bowel disease?[J]. Curr Opin Gastroenterol, 2018, 34(6): 377-383. DOI: 10.1097/MOG.0000000000000482.

FREEMAN G J, LONG A J, IWAI Y, et al . Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation[J ] . J Exp Med, 2000, 192(7): 1027-1034. DOI: 10.1084/jem.192.7.1027.

PINCHUK I V. PD-1 ligand expression by human colonic myofibroblasts/fibroblasts regulates CD4+ T-cell activity[J]. Gastroenterology, 2008, 135(4): 1228-1237. e2. DOI: 10.1053/j.gastro.2008.07.016.

WU W, SUN M M, ZHANG H P, et al . Prolactin mediates psychological stress-induced dysfunction of regulatory T cells to facilitate intestinal inflammation[J ] . Gut, 2014, 63(12): 1883-1892. DOI: 10.1136/gutjnl-2013-306083.

KEIR M E, BUTTE M J, FREEMAN G J, et al . PD-1 and its ligands in tolerance and immunity[J ] . Annu Rev Immunol, 2008, 26: 677-704. DOI: 10.1146/annurev.immunol.26.021607.090331.

CHULKINA M, BESWICK E J, PINCHUK I V. Role of PD-L1 in gut mucosa tolerance and chronic inflammation[J]. Int J Mol Sci, 2020, 21(23): 9165. DOI: 10.3390/ijms21239165.

CASSOL C A, OWEN D, KENDRA K, et al . Programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in PD-1 inhibitor-associated colitis and its mimics[J ] . Histopathology, 2020, 77(2): 240-249. DOI: 10.1111/his.14115.

NGUYEN J, FINKELMAN B S, ESCOBAR D, et al . Overexpression of programmed death ligand 1 in refractory inflammatory bowel disease[J ] . Hum Pathol, 2022, 126: 19-27. DOI: 10.1016/j.humpath.2022.04.011.

NAKAZAWA A, DOTAN I, BRIMNES J, et al . The expression and function of costimulatory molecules B7H and B7-H1 on colonic epithelial cells[J ] . Gastroenterology, 2004, 126(5): 1347-1357. DOI: 10.1053/j.gastro.2004.02.004.

LIU Y J, TANG B, WANG F C, et al . Parthenolide ameliorates colon inflammation through regulating Treg/Th17 balance in a gut microbiota-dependent manner. [J ] . Theranostics. 2020;10(12): 5225-5241. DOI: 10.7150/thno.43716.

AKHTAR M, RASHID S, AL-BOZOM I A. PD-L1 immunostaining: what pathologists need to know[J]. Diagn Pathol, 2021, 16(1): 94. DOI: 10.1186/s13000-021-01151-x.

YANG Z Y, WU G C, ZHANG X, et al . Current progress and future perspectives of neoadjuvant anti-PD-1/PD-L1 therapy for colorectal cancer[J ] . Front Immunol, 2022, 13: 1001444. DOI: 10.3389/fimmu.2022.1001444.

BOPANNA S, ANANTHAKRISHNAN A N, KEDIA S, et al . Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis[J ] . Lancet Gastroenterol Hepatol, 2017, 2(4): 269-276. DOI: 10.1016/S2468-1253(17)30004-3.

SELINGER C P, ANDREWS J M, TITMAN A, et al . Long-term follow-up reveals low incidence of colorectal cancer, but frequent need for resection, among Australian patients with inflammatory bowel disease[J ] . Clin Gastroenterol Hepatol, 2014, 12(4): 644-650. DOI: 10.1016/j.cgh.2013.05.017.

SCHULER C, FOTI F, PERREN L, et al . Deletion of Smad7 ameliorates intestinal inflammation and contributes to fibrosis[J ] . Inflamm Bowel Dis, 2022, izac221: ibd. DOI: 10.1093/ibd/izac221.

GARO L P, AJAY A K, FUJIWARA M, et al . Smad7 controls immunoregulatory PDL2/1-PD1 signaling in intestinal inflammation and autoimmunity[J ] . Cell Rep, 2019, 28(13): 3353-3366. e5. DOI: 10.1016/j.celrep.2019.07.065.

EICHELE D D, KHARBANDA K K. Dextran sodium sulfate colitis murine model: an indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis[J]. World J Gastroenterol, 2017, 23(33): 6016-6029. DOI: 10.3748/wjg.v23.i33.6016.

XU H M, ZHOU Y L, XU J, et al . Inhibition of PD-1 protects against TNBS-induced colitis via alteration of enteric microbiota[J ] . Biomed Res Int, 2021, 2021: 4192451. DOI: 10.1155/2021/4192451.

CURIEL T J, WEI S, DONG H D, et al . Blockade of B7-H1 improves myeloid dendritic cell-me diated antitumor immunity[J ] . Nat Med, 2003, 9(5): 562-567. DOI: 10.1038/nm863.

SONG M Y, HONG C P, PARK S J, et al . Protective effects of Fc-fused PD-L1 on two different animal models of colitis[J ] . Gut, 2015, 64(2): 260-271. DOI: 10.1136/gutjnl-2014-307311.

CHASSAING B, KUMAR M, BAKER M T, et al . Mammalian gut immunity[J ] . Biomed J, 2014, 37(5): 246-258. DOI: 10.4103/2319-4170.130922.

YAMADA A, ARAKAKI R, SAITO M, et al . Role of regulatory T cell in the pathogenesis of inflammatory bowel disease[J ] . World J Gastroenterol, 2016, 22(7): 2195-2205. DOI: 10.3748/wjg.v22.i7.2195.

FRANCISCO L M, SALINAS V H, BROWN K E, et al . PD-L1 regulates the development, maintenance, and function of induced regulatory T cells[J ] . J Exp Med, 2009, 206(13): 3015-3029. DOI: 10.1084/jem.20090847.

VAN DER VEEKEN J, CAMPBELL C, PRITYKIN Y, et al . Genetic tracing reveals transcription factor Foxp3-dependent and Foxp3-independent functionality of peripherally induced Treg cells[J ] . Immunity, 2022, 55(7): 1173-1184. e7. DOI: 10.1016/j.immuni.2022.05.010.

HARRISON O J, SRINIVASAN N, POTT J, et al . Epithelial-derived IL-18 regulates Th17 cell differentiation and Foxp3 + Treg cell function in the intestine[J ] . Mucosal Immunol, 2015, 8(6): 1226-1236. DOI: 10.1038/mi.2015.13..

JIANG Z Q, WU C. Reciprocal interactions between regulatory T cells and intestinal epithelial cells[J]. Front Immunol, 2022, 13: 951339. DOI: 10.3389/fimmu.2022.951339.

KONKEL J E, ZHANG D F, ZANVIT P, et al . Transforming growth factor-β signaling in regulatory T cells controls T helper-17 cells and tissue-specific immune responses[J ] . Immunity, 2017, 46(4): 660-674. DOI: 10.1016/j.immuni.2017.03.015.

CAO H, DIAO J, LIU H, et al . The pathogenicity and synergistic action of Th1 and Th17 cells in inflammatory bowel diseases[J ] . Inflamm Bowel Dis, 2022: 2022Sep27;izac199. DOI: 10.1093/ibd/izac199.

ALIYU M, ZOHORA F T, ANKA A U, et al . Interleukin-6 cytokine: an overview of the immune regulation, immune dysregulation, and therapeutic approach[J ] . Int Immuno-pharmacol, 2022, 111: 109130. DOI: 10.1016/j.intimp.2022.109130.

YASUDA K, TAKEUCHI Y, HIROTA K. The pathogenicity of Th17 cells in autoimmune diseases[J]. Semin Immunopathol, 2019, 41(3): 283-297. DOI: 10.1007/s00281-019-00733-8.

LEE J Y, HALL J A, KROEHLING L, et al . Serum amyloid A proteins induce pathogenic Th17 cells and promote inflammatory disease[J ] . Cell, 2020, 180(1): 79-91. e16. DOI: 10.1016/j.cell.2019.11.026.

WU B, ZHANG S, GUO Z L, et al . The TGF-β superfamily cytokine activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation[J ] . Immunity, 2021, 54(2): 308-323. e6. DOI: 10.1016/j.immuni.2020.12.010.

ALFEN J S, LARGHI P, FACCIOTTI F, et al . Intestinal IFN-γ-producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease[J ] . J Allergy ClinImmunol, 2018, 142(5): 1537-1547. e8. DOI: 10.1016/j.jaci.2017.12.984.

BRAND S, BEIGEL F, OLSZAK T, et al . IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration[J ] . Am J Physiol Gastrointest Liver Physiol, 2006, 290(4): G827-G838. DOI: 10.1152/ajpgi.00513.2005.

HUBER S, GAGLIANI N, ZENEWICZ L A, et al . IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine[J ] . Nature, 2012, 491(7423): 259-263. DOI: 10.1038/nature11535.

MAO K R, BAPTISTA A P, TAMOUTOUNOUR S, et al . Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism[J ] . Nature, 2018, 554(7691): 255-259. DOI: 10.1038/nature25437.

WU D, HU L N, HAN M W, et al . PD-1 signaling facilitates activation of lymphoid tissue inducer cells by restraining fatty acid oxidation[J ] . Nat Metab, 2022, 4(7): 867-882. DOI: 10.1038/s42255-022-00595-9.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

雌马酚干预对高脂饮食诱导的去卵巢大鼠非酒精性脂肪肝的影响

外周血炎症因子与房颤患者生活质量的关联研究

复方缓溃乐混悬剂对大鼠溃疡性结肠炎的治疗作用及机制

LPS诱导小鼠中性粒细胞mGluR5的表达及mGluR5在炎症中的作用

重组人Slit2蛋白预处理可减轻内毒素诱导的大鼠葡萄膜炎